busulfan has been researched along with Agammaglobulinemia in 7 studies
Agammaglobulinemia: An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood.
Excerpt | Relevance | Reference |
---|---|---|
"The pharmacokinetics of low-dose busulfan (BU) were investigated as a nonmyeloablative conditioning regimen for autologous gene therapy (GT) in pediatric subjects with adenosine deaminase-deficient severe combined immunodeficiency disease (ADA SCID)." | 7.96 | Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene Therapy. ( Ansari, M; Bradford, KL; Candotti, F; Garabedian, E; Gaspar, HB; Kohn, DB; Krajinovic, M; Liu, S; Shaw, KL; Tse, J; Wang, X, 2020) |
"The pharmacokinetics of low-dose busulfan (BU) were investigated as a nonmyeloablative conditioning regimen for autologous gene therapy (GT) in pediatric subjects with adenosine deaminase-deficient severe combined immunodeficiency disease (ADA SCID)." | 3.96 | Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene Therapy. ( Ansari, M; Bradford, KL; Candotti, F; Garabedian, E; Gaspar, HB; Kohn, DB; Krajinovic, M; Liu, S; Shaw, KL; Tse, J; Wang, X, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Vellaichamy Swaminathan, V | 1 |
Uppuluri, R | 1 |
Patel, S | 1 |
Melarcode Ramanan, K | 1 |
Ravichandran, N | 1 |
Jayakumar, I | 1 |
Vaidhyanathan, L | 1 |
Raj, R | 1 |
Bradford, KL | 1 |
Liu, S | 1 |
Krajinovic, M | 1 |
Ansari, M | 1 |
Garabedian, E | 1 |
Tse, J | 1 |
Wang, X | 1 |
Shaw, KL | 1 |
Gaspar, HB | 1 |
Candotti, F | 2 |
Kohn, DB | 2 |
Cooper, AR | 1 |
Lill, GR | 1 |
Shaw, K | 1 |
Carbonaro-Sarracino, DA | 1 |
Davila, A | 1 |
Sokolic, R | 1 |
Pellegrini, M | 1 |
Kanegane, H | 1 |
Taneichi, H | 1 |
Nomura, K | 1 |
Wada, T | 1 |
Yachie, A | 1 |
Imai, K | 2 |
Ariga, T | 1 |
Santisteban, I | 1 |
Hershfield, MS | 1 |
Miyawaki, T | 1 |
Tsuji, Y | 1 |
Morinishi, Y | 1 |
Kogawa, K | 1 |
Morino, M | 1 |
Nonoyama, S | 1 |
Patakfalvi, A | 1 |
Cohen, ML | 1 |
Weiss, EB | 1 |
1 trial available for busulfan and Agammaglobulinemia
Article | Year |
---|---|
Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients.
Topics: Adaptor Proteins, Signal Transducing; Adenosine Deaminase; Agammaglobulinemia; Antineoplastic Agents | 2017 |
6 other studies available for busulfan and Agammaglobulinemia
Article | Year |
---|---|
Treosulfan-based reduced toxicity hematopoietic stem cell transplantation in X-linked agammaglobulinemia: A cost-effective alternative to long-term immunoglobulin replacement in developing countries.
Topics: Agammaglobulinemia; Busulfan; Cost-Benefit Analysis; Developing Countries; Drug Therapy, Combination | 2020 |
Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene Therapy.
Topics: Adenosine Deaminase; Agammaglobulinemia; Busulfan; Child; Genetic Therapy; Hematopoietic Stem Cell T | 2020 |
Successful bone marrow transplantation with reduced intensity conditioning in a patient with delayed-onset adenosine deaminase deficiency.
Topics: Adenosine Deaminase; Agammaglobulinemia; Bone Marrow Transplantation; Busulfan; Child, Preschool; Hu | 2013 |
Successful unrelated cord blood transplantation for a patient with CD40 ligand deficiency.
Topics: Agammaglobulinemia; Busulfan; CD40 Antigens; Cord Blood Stem Cell Transplantation; Cyclophosphamide; | 2007 |
Secondary antibody deficiency syndrome in haemoblastosis.
Topics: Agammaglobulinemia; Antibodies; Antigens, Bacterial; Blood Protein Disorders; Blood Proteins; Busulf | 1972 |
Pneumocystitis carinii pneumonia: percutaneous lung biopsy and review of literature.
Topics: Adolescent; Adult; Agammaglobulinemia; Amphotericin B; Anuria; Azathioprine; Biopsy; Bis-Trimethylam | 1971 |